Patrys' shares halted
The halt will remain in place until Monday 15th January 2018.
Company
Patrys Ltd
ASX:PAB
Based in Melbourne, Australia, Patrys is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different indications.
68 stories · page 3 of 4
Patrys wins another U.S. patent for its unique cancer antibody
The antibody has shown great promise in laboratory and animal testing.
Patrys sits among Leading ASX % Gainers in afternoon trade
Patrys shares are climbing higher today following last weeks news.
Patrys is the ASX Most Traded, but losing momentum
Patrys shares are fading today, but the stock is still a three-bagger over past two days.
Patrys takes another gong riding near the top of the ASX Most Active
Patrys has traded over 84 million shares intra-day.
Patrys' positive pre-clinical data puts it on the podium of ASX Top % Gainers
Patrys has traded over 27 million shares in the first hour of the session.